Back
LivePerson 10K Form
Sell
32
LPSN
LivePerson
Last Price:
$0.86
Seasonality Move:
-2.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-10 | 10Q | LPSN/LivePerson Quarterly |
2023-11-09 | 10Q | LPSN/LivePerson Quarterly |
2023-08-09 | 10Q | LPSN/LivePerson Quarterly |
2023-05-11 | 10Q | LPSN/LivePerson Quarterly |
2022-11-08 | 10Q | LPSN/LivePerson Quarterly |
2022-08-09 | 10Q | LPSN/LivePerson Quarterly |
Receive LPSN News And Ratings
See the #1 stock for the next 7 days that we like better than LPSN
LPSN Financial Statistics
Sales & Book Value
Annual Sales: | $402M |
---|---|
Cash Flow: | $-972K |
Price / Cash Flow: | 0 |
Annual Sales: | $0.51 |
Price / Book: | 1.68 |
Profitability
EPS (TTM): | -1.53450 |
---|---|
Net Income (TTM): | $-62.7M |
Gross Margin: | $259.2M |
Return on Equity: | -139.32% |
Return on Assets: | -8.18% |
LivePerson Earnings Forecast
Key LivePerson Financial Ratios
-
The Gross Profit Margin over the past 26 years for LPSN is 64.47%.
-
The Selling, General & Administrative Expenses for LPSN have been equal to 53.17% of Gross Profit Margin.
-
The Research & Development expenses have been 31.04% of Revenue.
-
The Interest Expense is -0.16% of Operating Income.
-
The Net Earning history of LPSN is -24.98% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 12 years.
LivePerson Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | LPSN |
CUSIP: | 538146 |
Website: | liveperson.com |
Debt
Debt-to-Equity Ratio: | 10.24 |
---|---|
Current Ratio: | 1.27 |
Quick Ratio: | 1.17 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
LPSN Technical Analysis vs Fundamental Analysis
Sell
32
LivePerson (LPSN)
is a Sell
Is LivePerson a Buy or a Sell?
-
LivePerson stock is rated a SellThe current LivePerson [LPSN] share price is $0.85. The Score for LPSN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.